These guidelines are for manufacturers and the Official Analyst of the Therapeutic Goods Administration (TGA) Laboratories, and as guidance for referee testing when results are in dispute.
The guidelines have been updated to reflect the changes made to the British Pharmacopoeia sterility test method.